SG72610A1 - Therapeutic agent from my cobacterium vaccae and its use against hiv infection - Google Patents

Therapeutic agent from my cobacterium vaccae and its use against hiv infection

Info

Publication number
SG72610A1
SG72610A1 SG9601341A SG1996001341A SG72610A1 SG 72610 A1 SG72610 A1 SG 72610A1 SG 9601341 A SG9601341 A SG 9601341A SG 1996001341 A SG1996001341 A SG 1996001341A SG 72610 A1 SG72610 A1 SG 72610A1
Authority
SG
Singapore
Prior art keywords
cobacterium
vaccae
therapeutic agent
hiv infection
against hiv
Prior art date
Application number
SG9601341A
Other languages
English (en)
Inventor
John Lawson Stanford
Garham Arthur William Rook
Original Assignee
Stanford Rook Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stanford Rook Ltd filed Critical Stanford Rook Ltd
Publication of SG72610A1 publication Critical patent/SG72610A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SG9601341A 1992-09-14 1993-03-05 Therapeutic agent from my cobacterium vaccae and its use against hiv infection SG72610A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929219425A GB9219425D0 (en) 1992-09-14 1992-09-14 Therapeutic agent and its use

Publications (1)

Publication Number Publication Date
SG72610A1 true SG72610A1 (en) 2001-07-24

Family

ID=10721884

Family Applications (1)

Application Number Title Priority Date Filing Date
SG9601341A SG72610A1 (en) 1992-09-14 1993-03-05 Therapeutic agent from my cobacterium vaccae and its use against hiv infection

Country Status (18)

Country Link
EP (1) EP0661998B1 (ko)
JP (1) JPH06100457A (ko)
KR (1) KR100272743B1 (ko)
CN (1) CN1060937C (ko)
AP (1) AP510A (ko)
AT (1) ATE173633T1 (ko)
AU (1) AU683835B2 (ko)
BR (1) BR9303762A (ko)
CA (1) CA2105646A1 (ko)
DE (1) DE69322280T2 (ko)
DK (1) DK0661998T3 (ko)
ES (1) ES2125331T3 (ko)
GB (1) GB9219425D0 (ko)
HK (1) HK1011289A1 (ko)
RU (1) RU2106878C1 (ko)
SG (1) SG72610A1 (ko)
WO (1) WO1994006466A1 (ko)
ZA (1) ZA935575B (ko)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6406704B1 (en) 1996-08-29 2002-06-18 Genesis Research And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6284255B1 (en) 1996-08-29 2001-09-04 Genesis Research & Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US5985287A (en) * 1996-08-29 1999-11-16 Genesis Research And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6878377B2 (en) 1996-12-18 2005-04-12 Stanford Rook Limited Mycobacterium vaccae for down-regulation of the Th2 activity of the immune system
DK0951289T3 (da) * 1996-12-18 2006-03-13 Stanford Rook Ltd Anvendelse af Mycobacterium vaccae til behandling af kronisk træthedssyndrom
US5968524A (en) * 1997-12-23 1999-10-19 Genesis Research & Development Corp. Methods and compounds for the treatment of immunologically-mediated psoriasis
US6328978B1 (en) 1997-12-23 2001-12-11 Genesis Research & Development Corp. Ltd. Methods for the treatment of immunologically-mediated skin disorders
GB9903539D0 (en) 1999-02-16 1999-04-07 Stanford Rook Ltd Therapy using M.Vaccae
US6350457B1 (en) 1999-06-02 2002-02-26 Genesis Research & Development Corporation Limited Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccae
CA2472481A1 (en) * 2001-01-17 2002-07-25 Bakulesh Mafatlal Khamar Use of mycobacterium w for the treatment of human immunodeficiency virus (hiv) disease infection
WO2002056898A2 (en) * 2001-01-17 2002-07-25 Mafatlal Khamar Bakulesh Immunomodulator for the management of human immunodeficiency virus (hiv) disease/infection
WO2003063896A1 (en) * 2002-01-29 2003-08-07 Modi, Rajiv, Indravadan Process of preparing a pharmaceutical composition for immunity against tuberculosis in hiv positive individuals
BR0307262A (pt) * 2002-01-29 2006-12-19 Bakulesh Mafatlal Khamar método de prover profilaxia para tuberculose em indivìduos hiv positivos
WO2003075825A2 (en) * 2002-03-08 2003-09-18 Modi, Rajiv, Indravadan The method of treating tuberculosis

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0304897A2 (de) * 1987-08-25 1989-03-01 Burkhard Steglich Mittel zur Immunisierung des menschlichen Körpers bei HIV-Infektionen
WO1991001751A1 (en) * 1989-07-28 1991-02-21 University College London Biological preparation and its use

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0304897A2 (de) * 1987-08-25 1989-03-01 Burkhard Steglich Mittel zur Immunisierung des menschlichen Körpers bei HIV-Infektionen
WO1991001751A1 (en) * 1989-07-28 1991-02-21 University College London Biological preparation and its use

Also Published As

Publication number Publication date
ZA935575B (en) 1994-03-01
CA2105646A1 (en) 1994-03-15
ES2125331T3 (es) 1999-03-01
JPH06100457A (ja) 1994-04-12
BR9303762A (pt) 1994-03-22
DK0661998T3 (da) 1999-08-09
CN1060937C (zh) 2001-01-24
DE69322280D1 (de) 1999-01-07
AU3642093A (en) 1994-04-12
RU2106878C1 (ru) 1998-03-20
EP0661998B1 (en) 1998-11-25
KR950703360A (ko) 1995-09-20
ATE173633T1 (de) 1998-12-15
CN1089478A (zh) 1994-07-20
AU683835B2 (en) 1997-11-27
AP510A (en) 1996-07-23
DE69322280T2 (de) 1999-04-22
AP9300555A0 (en) 1993-10-31
HK1011289A1 (en) 1999-07-09
WO1994006466A1 (en) 1994-03-31
KR100272743B1 (ko) 2000-11-15
EP0661998A1 (en) 1995-07-12
GB9219425D0 (en) 1992-10-28

Similar Documents

Publication Publication Date Title
EP0831873A4 (en) COMBINATORY THERAPY FOR THE TREATMENT OF HIV AND OTHER VIRAL INFECTIONS
PH31600A (en) Methods of inhibiting atrophy of the skin and vagina.
SG72610A1 (en) Therapeutic agent from my cobacterium vaccae and its use against hiv infection
PL297849A1 (en) Vaccine against and method of treating the patients infectedwith hiv virus
HU9202095D0 (en) Therapy and vaccine against aids
AU2807492A (en) Use of misoprostol for the treatment of allergy
EP0462021A3 (en) Cholesterol-lowering agents and veterinary cholesterol-lowering agents
GB9222260D0 (en) Skin treatment
EP0428603A4 (en) Cytotoxic agent against specific virus infection
DE59306085D1 (de) Haar- und körperbehandlungsmittel
GB9217124D0 (en) Medical treatment
PL317876A1 (en) Combined treatment of hiv infections
AU1389897A (en) Use of chemokines for the treatment and prevention of hiv infection
EP0655919A4 (en) TREATMENT OF VIRAL INFECTIONS IN MAN.
EP0490250A3 (en) Use of interferon and an antimalarial agent for the treatment of malarial infections
IL105873A0 (en) Pyrimidinyl-and triazinyl-salicyl-and-picolyl-amides and the use and preparation thereof
GB9412618D0 (en) Cytotoxic agent and its use
GB9218773D0 (en) Skin treatment
AU3053595A (en) Therapeutic treatment and preparations
GB9412689D0 (en) Cytotoxic agent and its use
ZA925931B (en) Medicinal treatment
IL102796A0 (en) Medicinal treatment
EG19885A (en) Medicament for the treatment of hyperlipidaemia and/or atherosolerosis
KR940002718U (ko) 치질예방 및 치료기
ZA924842B (en) Asialoglycoprotein-conjugated medicinal agent